Related Experiment Video
Updated: Dec 14, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Cutaneous Effects of Notch Inhibitor Therapy: A Report of Two Cases
Claire J Wiggins1,2, Susan Y Chon1
1MD Anderson Cancer Center, Department of Dermatology, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Abstract:
As aberrant Notch signaling has been linked to cancerous growth, Notch inhibitors represent a novel category of targeted oncological therapy. Notch pathways in tumor cells may contribute to proliferation or limit apoptosis and differentiation. Healthy skin differentiation and homeostasis are reliant on normal Notch expression, and disruption of this signaling has been implicated in dermatological conditions such as hidradenitis suppurativa, psoriasis, atopic dermatitis, and lichen planus. Here, we describe two cases of patients with cutaneous side effects from Notch inhibitor treatment for adenoid cyst carcinoma (ACC) and review the role of Notch signaling in skin disease. By illuminating connections between medication side effects and disease pathogenesis, our goal is to increase awareness of the cutaneous side effects of Notch inhibitor treatment.
Insights
Notch inhibitors, used for cancer therapy, can cause skin issues. This study highlights these side effects and their link to skin diseases, improving awareness for better patient care.
Area of Science:
- Oncology and Dermatology
- Molecular Biology
- Translational Medicine
Background:
- Aberrant Notch signaling is implicated in various cancers, making Notch inhibitors a promising targeted oncological therapy.
- Notch signaling is crucial for normal skin differentiation and homeostasis; its disruption is linked to dermatological conditions like psoriasis and atopic dermatitis.
Observation:
- Two cases of cutaneous side effects in patients treated with Notch inhibitors for adenoid cyst carcinoma (ACC) are presented.
- These side effects suggest a complex interplay between Notch inhibition and skin biology.
Findings:
- Notch inhibitor treatment can lead to adverse skin reactions, impacting healthy skin homeostasis.
- The study reviews the role of Notch signaling in skin disease pathogenesis and its connection to treatment side effects.
Implications:
- Increased awareness of Notch inhibitor-induced cutaneous side effects is crucial for oncologists and dermatologists.
- Understanding these connections can inform clinical management and potentially lead to strategies to mitigate skin toxicity.
- This research bridges oncology and dermatology, offering insights into targeted therapy side effects and skin disease mechanisms.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells
Papillary Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen...

